Medication practices in Bangladesh-roles of pharmacists at current circumstances

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue SUPPL. 4, 2011, Pages 5-8

  Shill, Manik Chandra ^a   Das, Asish Kumar ^b  

^a IPD Pharmacy   (Bangladesh)

^b KHULNA UNIVERSITY   (Bangladesh)

Author keywords

Healthcare system; Hospital and community pharmacy; Irrational drug use; Medication error; Pharmacist

Indexed keywords

BANGLADESH; DRUG COST; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MONITORING; DRUG QUALITY; DRUG USE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; MEDICATION ERROR; PATIENT COUNSELING; PHARMACIST; PHARMACY; PRESCRIPTION; REVIEW;

EID: 80052679000     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. NCC MERP National Coordinating Council for Medication Error Reporting and Prevention, 2009. "About Medication Errors." (http://www.nccmerp.org/aboutMedErrors.html).
2. ISMP The Institute for Safe Medication Practices. 2008. "Heparin Errors Continue Despite Prior, High-Profile, Fatal Events." ISMP Newsletter, July 17, 2008. (http://www.ismp.org/Newsletters/acutecare/articles/20080717.asp).
3. Kohn LT, Corrigan JM, and Donaldson MS. To Err is Human: Building a Safer Health System. Washington, D.C.: National Academy Press, Institute of Medicine, 1999. (http://www.nap.edu/books/0309068371/html).
4. Lazarou J, Pomeranz B, Corey P. Incidence of Adverse Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA 1998; 279: 1200-1205.
5. Pirmohamed M, Atuah KN, Dodoo ANO, Winstanley P. Pharmacovigilance in Developing Countries. BMJ 2007; 335: 462.
6. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events, Implications for prevention. JAMA 1995; 274: 29-34.
7. Bhatt AD, Healthcare Management, 2002. (http://www.expresshealthcaremgmt.com/20020630/edit2.html).
8. Chowdhury SAR. Prescribing a rational drug. Bangladesh Journal of Physiology and Pharmacology 1991; 7: 182-187.
9. Bangladesh National Health Accounts, 1996-1997. Health Economic Units, Ministry of Health and Family Welfare, Bangladesh. (http://www.apnhan.org/territories/bgd/docs/BangladeshNH_A1996-97.pdf).
10. Bangladesh Public Health Conference, 2008 (http://www.unnayan.org/reports/Report_BPC_08.pdf).
11. National Drug Policy 2005, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh. (http://www.ddabd.org/download/drug_policy_2005_eng.pdf).
12. Roy J. The menace of substandard drugs. World Health Forum 1994; 15: 406-407.
13. Smith G. What FIP and WHO are doing to fight the problem of counterfeit drugs? Pharm J 2004; 273: 394-396.
14. Govt. deprived of revenue, adulterated medicines being sold: Mushroom growth of pharmacies, 70,000 shops trading without licenses. The Bangladesh Observer, 2003. (http://www.bangladeshobserveronline.com/new/2003/09/17/district.htm).
15. War against fake drugs waged. The Daily Star, 2003. (http://www.thedailystar.net/2003/11/14/d3111401011.htm).
16. Ahmed F, Das AK, Karmakar UK, Khaleque T, Shill MC. Quality of Marketed Metronidazole Preparations in Bangladesh - An Analytical Overview. Journal of Biological Science 2003; 3: 940-950.
17. Hossain A, Rafiquzzaman R, Haque M. Studies on quality of marketed drugs "ciprofloxacin" a case study. Proceedings of the International Conference on Pharmaceutical Affairs, 2001; Kathmandu, Nepal, 172.
18. Islam MS. Therapeutic drug use in Bangladesh: policy versus practice. Indian J Med Ethics 2008; 5:24-25.
19. Spurious medicines. New Nation, 2006 Sep 24. (http://nation.ittefaq.com/artman/publish/article_31014.shtml)
20. Hanif M, Mobarak MR, Ronan A, Rahman D, Donovan JJ, Bennish ML. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. BMJ 1995; 311: 88.
21. Sengupta A. The paracetamol syrup tragedy. The Financial Express. August 2, 2009. (http://www.thefinancialexpress-bd.com/2009/08/02/74962.html).
22. Rid's syrup unauthorised, toxic element found. The Daily Star. July 30, 2009. (http://www.thedailystar.net/newDesign/news-details.php?nid=99261).
23. Management sciences for Health, Managing drug supply, West Hartford, Connecticut, USA, Kumarian Press, 1997.
24. Hogerzeil HV. Promoting Rational Prescribing: an International Perspective. International experience in rational use of drugs. Br J Clin Pharmacol 1995; 39:1-6.
25. Guyon AB, Barman A, Ahmed JU, Ahmed AU, Aiam MS. A baseline survey on use of drugs at the primary health care level in Bangladesh. Bulletin of the World Health Organization 1994; 72: 265-271.
26. Chowdhury FR, Rahman MM, Huq MF, Begum S. Rationality of drug uses: its Bangladeshi perspectives. Mymensingh Medical Journal. 2006; 15: 215-219.
27. Sultana S, Hamid K, Islam KMS, Roy S, Saha MR, Zulfiker AHM, Urmi KF. Assessment of Prescription Pattern of Hypertensive Patient's Prescription: A Prescription Survey Study from Various Hospitals of Bangladesh, European Journal of Scientific Research 2010; 40: 500-505.
28. Banglapedia (National Encyclopedia of Bangladesh). Rational Use of Drugs. 1st Edition (February 2004). Asiatic Society of Bangladesh, Dhaka.
29. Mamun KZ, Tabassum S, Shears P, Hart CA. A survey of antimicrobial prescribing and dispensing practices in rural Bangladesh. Mymensingh Medical Journal 2006; 15: 81-84.
30. Baqui AH, Black RE, Arifeen SE, Yunus M, Zaman K, Begum N et al. Zinc Therapy for Diarrhoea Increased the Use of Oral Rehydration Therapy and Reduced the Use of Antibiotics in Bangladeshi Children. Journal of Health, Population and Nutrition 2004; 22: 440-442.
31. Fahad BM, Matin A, Shill MC, Das AK. Pilot Study of Antibiotic Usage pattern at a primary health care unit at Bangladesh. Australasian Medical Journal 2010; 3: 414-421.
32. Mudur G. Abuse of OTC drugs rising in South Asia. BMJ 1999; 318:556.
33. Ahmed SM. Exploring Health-seeking behaviour of disadvantaged populations in rural Bangladesh (PhD Dissertation, No. 05/433). Karolinska University Press. Sweden; 2005. (http://diss.kib.ki.se/2005/91-7140-435-X/).
34. Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care 2005; 14: 207-211.
35. Prevention of Medication Errors Information Statement. American Academy of Orthopaedic Surgeons. (http://www.aaos.org/about/papers/advistmt/1026.asp).
36. Walton SM. The Pharmacist Shortage and Medication Errors: Issues and Evidence. Journal of Medical Systems 2004; 28(1):63-69.
37. Suleiman A, Sulaiman S, Albarq A. Hospital Admission And Poor Adherence To Antihypertensive Therapy: Is There Any Relationship? International Journal of Pharmacy and Pharmaceutical Sciences 2009; 2: 38-46.
38. Reema T, Adepu R, Sabin T. Impact of Clinical Pharmacist Intervention on Knowledge, Attitude and Practice (KAP) of Patients with Chronic Obstructive Pulmonary Disease. International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2: 54-57.
39. Role of Pharmacist (http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/Browsable/DH_5355019).
40. Ishita, Kaushik D, Dureja H. Role of community pharmacist in ensuring better healthcare (http://www.pharmabiz.com/article/detnews.asp?articleid=2 2582§ionid=46).
41. Pahwa R, Sharma A, Sharma P, Sharma PC. Role of pharmacist in safe use of medicines (http://www.pharmabiz.com/article/detnews.asp?articleid=4 2883§ionid=46).
42. David U. Medication Safety Alert. CJHP 2003; 56: 97-99.